ArticleHuman vaccines & immunotherapeutics2025
The effect of mumps vaccine on the incidence of mumps in Hefei: An interrupted time-series analysis.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To quantitatively assess the incremental protective effect of two-dose mumps vaccination in Hefei. Monthly mumps incidence during 2011-2023 were collected. The Interrupted Time Series and Segmented Regression Analyses (ITSA) were employed to evaluate the variations in monthly mumps incidence following the introduction of one-dose mumps-containing vaccine (MuCV) and two-dose measles-mumps-rubella combined attenuated live vaccine (MMR) into the Expanded Program on Immunization (EPI). The average annual incidence was 16.95 per 100,000 population (18.75 and 10.95 in one-dose and two-dose vaccination periods respectively). The incidence was the highest among children aged 5-14. ITSA revealed that monthly incidences of mumps decreased by 0.015 per 100,000 (β
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.